WO2008114272A3 - Procédé de préparation d'alfuzosine - Google Patents

Procédé de préparation d'alfuzosine Download PDF

Info

Publication number
WO2008114272A3
WO2008114272A3 PCT/IN2007/000523 IN2007000523W WO2008114272A3 WO 2008114272 A3 WO2008114272 A3 WO 2008114272A3 IN 2007000523 W IN2007000523 W IN 2007000523W WO 2008114272 A3 WO2008114272 A3 WO 2008114272A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparing
alpuzosin
alfuzosin hydrochloride
hydrochloride
crystalline
Prior art date
Application number
PCT/IN2007/000523
Other languages
English (en)
Other versions
WO2008114272A2 (fr
Inventor
Kuldeep Natwarlal Jain
Shriprakash Dhar Dwivedi
Original Assignee
Cadila Healthcare Ltd
Kuldeep Natwarlal Jain
Shriprakash Dhar Dwivedi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd, Kuldeep Natwarlal Jain, Shriprakash Dhar Dwivedi filed Critical Cadila Healthcare Ltd
Publication of WO2008114272A2 publication Critical patent/WO2008114272A2/fr
Publication of WO2008114272A3 publication Critical patent/WO2008114272A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

La présente invention concerne des procédés de préparation d'alfuzosine et de sels, solvates et hydrates pharmaceutiquement acceptables de celle-ci. La présente invention concerne également des procédés de préparation de chlorhydrate d'alfuzosine anhydre substantiellement dépourvu d'autres formes cristallines pseudopolymorphes, particulièrement de forme dihydrate de chlorhydrate d'alfuzosine.
PCT/IN2007/000523 2007-03-22 2007-11-05 Procédé de préparation d'alfuzosine WO2008114272A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN522MU2007 2007-03-22
IN522/MUM/2007 2007-03-22

Publications (2)

Publication Number Publication Date
WO2008114272A2 WO2008114272A2 (fr) 2008-09-25
WO2008114272A3 true WO2008114272A3 (fr) 2009-04-09

Family

ID=39591789

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2007/000523 WO2008114272A2 (fr) 2007-03-22 2007-11-05 Procédé de préparation d'alfuzosine

Country Status (1)

Country Link
WO (1) WO2008114272A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008281567B2 (en) 2007-08-02 2012-07-26 Cipla Limited Process for the preparation of alfuzosin hydrochloride
CN114573569B (zh) * 2022-03-30 2023-07-04 邦恩泰(山东)生物医药科技集团股份有限公司 一种异喹啉类化合物的制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545738A (en) * 1993-12-28 1996-08-13 Synthelabo Alfuzosin hydrochloride dihydrate
WO2006090268A2 (fr) * 2005-02-28 2006-08-31 Glenmark Pharmaceuticals Limited Procedes de preparation d'alfuzosine et de ses sels, nouvelles formes cristallines d'alfuzosine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545738A (en) * 1993-12-28 1996-08-13 Synthelabo Alfuzosin hydrochloride dihydrate
WO2006090268A2 (fr) * 2005-02-28 2006-08-31 Glenmark Pharmaceuticals Limited Procedes de preparation d'alfuzosine et de ses sels, nouvelles formes cristallines d'alfuzosine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
R. GABRIEL, P. HRADIL, J. WALLA: "anhydrous N-[3-[4-amino-6,7-dimethoxy-2-quinazoliny)methylamino]propyl]tetrahydro-2-furancarboxamide, its preparation and stabilisation", ACTA UNIVERSITATIS PALACKIANAE OLOMOUCENSIS FACULTAS RERUM NATURALIUM, vol. 44, 2005, pages 49 - 53, XP009111040 *

Also Published As

Publication number Publication date
WO2008114272A2 (fr) 2008-09-25

Similar Documents

Publication Publication Date Title
WO2009084024A3 (fr) Procédé pour la préparation de r-sitagliptine et de ses sels pharmaceutiquement acceptables
WO2009062044A3 (fr) Procédés de préparation de prasugrel et ses sels et polymorphes
WO2009025873A3 (fr) Procédés pour la préparation de formes cristallines a, b et d'une forme a cristalline pure de chlorhydrate d'erlotinib
WO2008039489A3 (fr) Dérivés de quinazolinone substitués en 5', compositions contenant ces dérivés et procédés d'utilisation
WO2011042918A3 (fr) Procedes perfectionnes et nouveaux de preparation de prasugrel, de ses intermediaires et de sels de qualite pharmaceutique
WO2007027527A3 (fr) Composes d'isoindole-imide et compositions renfermant ceux-ci et procedes d'utilisation de ceux-ci
WO2008076046A8 (fr) Nouveaux 2-amino-5, 5-diaryl-imidazol-4-ones
MX2009012168A (es) Derivados de pirrolopiridina y su uso como inhibidores de la enzima que escinde la proteina precursora de amiloide por el sitio beta.
WO2007136510A3 (fr) FORMES POLYMORPHES DE MÉSYLATE D'IMATINIBE ET PROCÉDÉS DE PRÉPARATION DE NOUVELLES FORMES CRISTALLINES ET AMORPHES ET DE FORME α
WO2009066326A3 (fr) Procédé amélioré pour la préparation de prasugrel et de ses sels pharmaceutiquement acceptables
WO2008120080A3 (fr) Procédé amélioré de synthèse de solifénacine
TNSN08191A1 (en) Kinase inhibitors
WO2008021342A3 (fr) Formes cristallines de la 9-hydroxy-rispéridone (palipéridone)
WO2010062715A3 (fr) Polymorphes de dasatinib et leur procédé de préparation
WO2010129918A8 (fr) Promédicaments à base de triptolide
MX2009008660A (es) Metodo para la preparacion de derivados de trifenilbuteno terapeuticamente valiosos.
WO2010070449A3 (fr) Laquinimode très pur ou sel pharmaceutiquement acceptable de celui-ci
WO2008062282A3 (fr) Procédé perfectionné pour la synthèse de solifénacine
WO2006090268A3 (fr) Procedes de preparation d'alfuzosine et de ses sels, nouvelles formes cristallines d'alfuzosine
WO2010070677A3 (fr) Procédé de préparation de prasugrel et de ses sels pharmaceutiquement acceptables
WO2008001201A3 (fr) Compositions pharmaceutiques de clopidogrel
WO2008051564A3 (fr) Formes cristallines d'hydrochlorure de palonosetron
WO2007112913A3 (fr) Derives de benzimidazole
WO2008117305A3 (fr) Nouveau procédé pour préparer de la prégabaline et ses sels d'addition avec les acides
WO2008019057A3 (fr) Polymorphes d'un intermédiaire de la solifénacine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07870519

Country of ref document: EP

Kind code of ref document: A2

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07870519

Country of ref document: EP

Kind code of ref document: A2